Home›Stock Screener›Laurus Labs›Quarterly Results

Laurus Labs Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹282 Cr
QMar 2026
Quarterly Results

In Mar 2026, Laurus Labs (LAURUSLABS) reported revenue ₹1,823 Cr and net profit ₹282 Cr — revenue +2.5% YoY. For annual financials, live price and key ratios, visit LAURUSLABS share price screener.

LAURUSLABS Quarterly Results — Revenue, Profit & EPS Highlights

Laurus Labs latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View Laurus Labs yearly highs lows for the annual high/low range and current price position.

  • Revenue of ₹1,823 Cr in Mar 2026 (-10.5% vs Jun 2026, +2.5% vs Mar 2025)
  • Net Profit of ₹282 Cr in Mar 2026 (-22.1% vs Jun 2026, +21.0% vs Mar 2025)
  • EBITDA of ₹524 Cr in Mar 2026 (-19.1% vs Jun 2026)
  • Operating Margin of 28.0% in Mar 2026 (-4.0pp vs Jun 2026)
  • Earnings Per Share of ₹5.17 in Mar 2026 (-24.1% vs Jun 2026)

Laurus Labs Quarterly Results — Revenue, EBITDA, Net Profit & EPS

LAURUSLABS quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 1,823 2,036 1,680 1,779 1,580 -10.5% 2.5%
Net Profit (₹ Cr) 282 362 195 233 162 - -
EBITDA (₹ Cr) 524 648 430 479 393 - -
EPS (₹) 5.17 6.81 3.61 4.34 3.02 - -
Operating Margin (%) 28.0% 32.0% 24.0% 24.0% 24.0% - -

LAURUSLABS Share Price Trend — 1-Year Movement Across Quarterly Results

Laurus Labs 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse LAURUSLABS shareholder distribution to track promoter, FII and institutional holdings.

Profitability Ratios

Profit Margin 15.5%
EBITDA Margin 28.7%
Operating Margin 28.0%
ROE (Annual) 20.8%

Balance Sheet Highlights

Total Assets ₹10,511 Cr
Total Equity ₹5,431 Cr
Current Assets ₹4,829 Cr
Current Liabilities ₹1,444 Cr

Cash Flow Analysis

Operating Cash Flow ₹1,624 Cr
Investing Cash Flow ₹-1,086 Cr
Financing Cash Flow ₹-525 Cr
Net Cash Flow ₹13 Cr

Current Market Data

Current Price ₹1954.00
Exchange NSE
Last Updated Sep 18, 2026

Revenue Trend (₹ Cr)

Mar 2025 1,779
Sept 2025 1,680
Jun 2026 2,036
Mar 2026 1,823

Net Profit Trend (₹ Cr)

Mar 2025 233
Sept 2025 195
Jun 2026 362
Mar 2026 282

Operating Margin Trend (%)

Mar 2025 24.0%
Sept 2025 24.0%
Jun 2026 32.0%
Mar 2026 28.0%

LAURUSLABS vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Laurus Labs latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹441,477.63 Cr 1837.3 15,018 2,710 -5.6% - 18.0% 162.6
Divis Laboratories
Mar 2026 		₹247,469.81 Cr 9375.0 2,986 751 -5.0% - 25.2% 331.2
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4840.0 4,111 364 +27.7% +42.2% 8.9% 420.5
Zydus Life Science
Mar 2026 		₹112,607.65 Cr 1160.0 7,569 1,341 -4.3% - 17.7% 91.7
Cipla
Mar 2026 		₹109,705.39 Cr 1394.5 6,612 543 -9.3% - 8.2% 203.0
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores